Leaders in Ion Channel Drug Discovery
Metrion Biosciences is a specialist ion channel contract research organisation providing drug discovery services to pharmaceutical and bioscience customers worldwide.
Metrion Biosciences announces launch of Good Laboratory Practice (GLP) hERG Screening Service
Download our new GLP hERG Screening brochure
Metrion Biosciences
Latest News
Metrion Biosciences closes £3.7m new equity financing
20th December 2023
Metrion Biosciences Limited (Metrion), the specialist ion channel CRO and drug discovery company, today announced that it has secured £3.7m in new equity financing, including £2.5m from lead investor Maven Capital Partners (Maven) and £1 million from existing investor, Gresham House Ventures (Gresham House). The funding will be used to further expand Metrion’s laboratories in Cambridge, UK, invest in specialist equipment and enhance the Company’s global marketing activities.
Metrion Biosciences announces launch of Good Laboratory Practice (GLP) hERG Screening Service
1st August 2023
Metrion Biosciences Limited (“Metrion”), the specialist ion channel contract research and drug discovery company, today announced it has received notification from the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) that the Company is now a member of the UK GLP (Good Laboratory Practice) Compliance Monitoring Programme, and is therefore able to offer GLP compliant hERG ion channel screening services to the global life sciences community.
Our Services
Ion Channel Screening
Cardiac Safety Screening
Neuroscience
Translational Assays
Integrated Drug Discovery
Video
Metrion Biosciences’ Neuroscience Services
6th July 2023
Here we share a short video introducing Metrion’s Neuroscience service capabilities. To learn more, or to request a quote, please email info@metrionbiosciences.com
- ‘Let’s Cure CLCN4’ rare disease channelopathy drug discovery symposium report
- Molly – My Placement At Metrion So Far
- The CICF 2023 – My Perspectives
- Jack – My Academic and Professional Career So Far!
- Zeki – From Ants to Ion Channels
- Thomas’s Career So Far
News and Upcoming Events
Read news including equity financing, launch of GLP hERG Screening service, key appointments, collaboration with KCNC1 Foundation, High-Throughput Screening, expansion of ion channel screening services.
For media enquiries please email us here.
We hold and participate in numerous events each year for professional development, knowledge sharing, self-improvement and networking opportunities.
Please schedule a meeting with us to discuss any questions or any specific ion channel and assay requirements. We look forward to meeting you shortly.
Receive the latest ion channel and cardiac safety news and insights to your inbox
Our quarterly newsletter is packed full of the latest Ion Channel news and reviews. We cover events, webinars, research findings, and publications and insights from our team, partners, and distinguished guests.
Let’s work together
What are your specific ion channel and assay needs?
If you have any questions or would like to discuss your specific assay requirements, we will put you directly in touch with a member of our scientific team. Contact us today to discover more.